Pregnancy in the Elderly

As the speech goes: Age isn’t anything however a number. But once it comes to getting pregnant and having a healthy pregnancy, it will matter. Increasingly, pregnancy with advanced maternal age is becoming common. Rest assured, most healthy women who get pregnant after age thirty five and even into their 40’s have healthy babies. A dedicated panel is planned to address this with special emphasis to periconceptional issues.

How Can I Increase My Chances of Having a Healthy Baby?
Preconception checkups and counseling. Once you decide that you just are ready to have a baby, it's necessary to take some steps before conception. See your doctor for a examination to create positive your are healthy before conception. Consult Doctor to create positive you're emotionally ready for pregnancy.

Get early and regular prenatal care. The first eight weeks of your pregnancy are important to your baby's development. Early and regular antepartum care will increase your probabilities of getting a secure pregnancy and a healthy baby. antepartum care includes screenings, regular exams, pregnancy and birth education, and counseling and support.

Getting prenatal care also helps give additional protection for women over thirty five. It permits your doctor to remain prior to health conditions that are a lot of common in women who are older when they get pregnant. As an example, your age might increase your risk for gestational polygenic disease and preeclampsia, a condition that causes high vital sign at the side of protein in the urine. During prenatal visits, your doctor will check your vital sign, take a look at your urine for protein and sugar, and take a look at your glucose levels. That way, any potential issues will be caught and treated early.

Consider optional prenatal tests for women over 35. Your doctor might give you special prenatal tests that are notably applicable for older moms. These tests facilitate determine the chance of having a baby with a defect. Ask your doctor regarding these tests thus you'll be able to learn the risks and benefits and choose what is right for you.

Take prenatal vitamins. All women of childbearing age ought to take a daily prenatal vitamin containing a minimum of four hundred micrograms of folic acid. Obtaining enough folic acid a day before and through the first three months of pregnancy will facilitate stop defects involving a baby's brain and spinal cord. Taking folic acid adds a very important level of protection for older women, who have a higher risk of getting a baby with birth defects. Some prenatal vitamins have 800-1,000 weight unit of folic acid. This is still safe in pregnancy. As a matter of truth, some women want over four hundred mcg for defense against birth defects. Don’t take more than 1,000 mcg (1 milligram) of folic acid while not asking your doctor. Women with a history of a baby with neural tube defects need 4000 mcg.

The Ovary

Oocyte and ovarian tissue cryopreservation - Recent advances in oocyte and ovarian tissue cryopreservation technology have brought hope not only to women facing premature loss of ovarian function, but also to healthy women seeking delayed motherhood. This is a major issue of contention in healthcare ethics. Proponents of this new technology argue that this enables women to pursue educational and career goals in their youth, so that they have greater financial security for children in later life. Nevertheless, this argument may be flawed by the reality that even if the cryopreservation of oocytes and ovarian tissue were optimized in the future, this would in no way be a guaranteed route for women to have biological children later in life.

Assessment of ovarian ageing and Dilemmas of Ovarian stimulation - The main objective of individualization of treatment in ART is to offer every single woman the best treatment tailored to her own unique characteristics, thus maximizing the chances of pregnancy and eliminating the iatrogenic and avoidable risks resulting from ovarian stimulation. Personalization of treatment in IVF should be based on the prediction of ovarian response for every individual. The starting point is to identify if a woman is likely to have a normal, poor or a hyper response and choose the ideal treatment protocol tailored to this prediction. 

The objective of this conference with the theme “The Ovary” is to review and summarize the predictive ability of ovarian reserve markers, such as antral follicle count (AFC) and anti-Mullerian hormone (AMH), and the therapeutic strategies for ovarian stimulation, be it ovulation induction, super ovulation or controlled ovarian stimulation.

Endometriosis - The specific impact of endometrioma alone and the impact of surgical intervention for endometrioma on the reproductive outcome of women undergoing IVF/ICSI are areas that require further clarification. The objectives of this conference with regards to endometrioma are as follows: (i) to determine the impact of endometrioma on IVF/ICSI outcomes, (ii) to determine the impact of surgery for endometrioma on IVF/ICSI outcome and (iii) to determine the effect of different surgical techniques on IVF/ICSI outcomes.

PCOS - Treatment of patients with polycystic ovary syndrome (PCOS) with assisted reproductive techniques is a great challenge for the infertility specialist. Patients with PCOS demonstrate many problems, such as excessive body weight and hyperinsulinaemia, that render management more complex. In this conference topics covered under PCOS include ‘Innovations in ovulation induction (OI)’, ‘Treatment strategies in women who fails to conceive after 3 cycles of OI, Insulin resistance, Homocysteine and Pregnancy loss in PCOS : are they related?


Recurrent Pregnancy Loss

Are there factors influencing recurrent pregnancy loss beyond genetics?
Will early and appropriate identification and management of all factors (metabolic, thrombophilia, anatomical etc) make a difference to the outcomes?

Recurrent Pregnancy Loss

These questions will be answered by a dedicated plenary session and also an interactive session with the experts to allow one to one clarification of clinical queries on patient management.
Each day in practice especially during management of high risk pregnancies is litigation prone. Dealing with this effectively in an interesting panel with lawyers, obstetricians and neonatologists who will discuss the practical measures and the do’s and dont’s of this with appropriate clinical scenarios.

In utero fetal programming

Sonographic surveillance for fetal macrosomia will add value to avert perinatal complications – A session by Dr. Ramamurthy B.S. 

Influence of intrahepatic cholestasis of pregnancy (IHCP) on inutero fetal programming – Can it influence childhood obesity?

Inutero fetal programming is a recent evolving concept. Managing pregnancy effectively not only to avert maternal complications but also too effectively programme the fetus inutero so that it could minimise the predisposition to disease ( metabolic problems ) later during adult life is the essence of this concept.

Recent and relevant topics like influence of ‘Intrahepatic cholestasis of pregnancy, ultrasound prediction and surveillance of fetal macrosomia have been included’.

IHCP, management dilemmas and more to be discussed in the plenary session on Day 2 of Life Conference 2016.

Life Conference is a medicalconference, normally held in Bangalore, which covers the latest trends and techniques in the fields of Ultrasound in the arena of Infertility and Fetal Medicine. It comprises of live demonstration workshops, keynote addresses and a robust scientific program with a host of well-known National & International speakers who ensure that the delegates get sufficient exposure to the advances in the field from all over the world.